Cowen Financial Products LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-01-24 2:44 pm Sale | 2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP | Cowen Financial Products LLC | 1,500,326 3.280% | -799,674 (-34.77%) | Filing |
| 2022-01-19 3:43 pm Purchase | 2022-01-14 | 13G | PMV Pharmaceuticals, Inc. PMVP | Cowen Financial Products LLC | 2,300,000 5.070% | 2,300,000 (New Position) | Filing |